AI/ML Innovations Announces Completion of Share Issuance
AI/ML Subsidiary NeuralCloud Appoints Cardiac Monitoring Veterans Dale and Nicholas DuBois to Lead Clinical and Overread Operations
AI/ML Innovations Inc. Announces Closing of Final Tranche of Private Placement to Raise $1,917,500
AIML Appoints Dr. Martin Green to Medical Advisory Board and Issue Options
AI/ML Innovations Announces Completion of Share Issuance
AI/ML Innovations Announces Completion of Share Issuance
Neural Cloud Signs Reseller Agreement with European Digital Cardiac Monitoring Platform
AI/ML Innovations Inc. Announces Closing of First Tranche of Private Placement to Raise $950,000
AIML Subsidiary NeuralCloud Enters Research Services Agreement with Baker Heart and Diabetes Institute to Support AI-Driven ECG Analysis
AI/ML Innovations Inc. Announces Proposed Private Placement of Convertible Debentures
Neural Cloud Enters Distribution Agreement with Intelimed to Expand into Latin America
AIML Subsidiary NeuralCloud Signs Non-Binding Agreement with Movesense to Pilot AI-Powered ECG and Holter Reporting
Neural Cloud Retains Commission Wolf to Accelerate U.S. Commercial Expansion
AIML Appoints Dr. Paul Dorian as Medical Innovation Architect and Head of the Medical Advisory Board
AIML Subsidiary NeuralCloud Collaborates with Movesense to Expand Bundled ECG Solutions for Clinical and Wellness Markets
AIML subsidiary NeuralCloud Solutions Inc., Signs Non-Binding Commercial Term Sheet with Lakeshore Cardiology to Deploy CardioYield(TM) for AI-Powered Holter Analysis
AI/ML Appoints Erik Suokas as Chief Operating Officer to Accelerate Commercial Execution and Operational Scale
AIML Announces the Conclusion of Consulting Agreement and Leadership Transition for President & Chief Commercial Officer
Join AIML's Live Shareholder Update with Chairman & CEO Paul Duffy
AIML subsidiary NeuralCloud Solutions Signs Commercial Term Sheet with Culminate H Labs to Deploy MaxYield(TM) and Insight360(TM) into INTRINSICA's DNA-Guided Biofeedback Wellness Ecosystem
AIML Subsidiary NeuralCloud Enters Pilot with Cornerstone Physiotherapy to Deploy MaxYield(TM) and Insight360(TM) for Elite Athlete Cardiac Performance Testing
AIML Subsidiary NeuralCloud Signs Commercial Term Sheet With Equimetrics To Deploy Maxyield(TM) And Cardioyield(TM) Across Equine Cardiac Monitoring Platforms
AI/ML Subsidiary Neural Cloud Begins Pilot at SickKids to Advance AI-Enabled Pediatric Cardiac Care
AI/ML Innovations Inc. Announces Grant of U.S. Patent Protecting Core ECG Signal-Processing Architecture
AIML Subsidiary NeuralCloud Solutions Engages Lonacas Consultants to Lead Regulatory Submission for CardioYield(TM) in Jamaica
AIML Subsidiary NeuralCloud Solutions Commencing Pilot with Canadian Cardiology Clinic to Advance AI-Powered ECG Reporting
AIML Subsidiary NeuralCloud Solutions and Heartdent Center Ltd. Launch Pilot Project to Advance Cardiac Care in Jamaica
AIML Subsidiary NeuralCloud Solutions and Toronto Heart Centre Launch a Pilot Program to Test AI-Powered Holter ECG Reporting
AIML and BC Brain Wellness Program Launch Pilot to Explore the Heart–Brain Connection
AIML Announces Closing of Oversubscribed Private Placement
AIML Announces Proposed Private Placement
AIML Announces SEDAR Filing
AIML Innovations Closes Quantum Sciences Ltd. Restructuring
AIML Strengthens IP Portfolio with Provisional Patents for AI Driven ECG Signal Processing
AI/ML Establishes Innovation Committee, Appoints Dr. Drew Dundas as Chair
AIML Hits Key Regulatory Benchmark with 510(k) Filing for MaxYield(TM) Signal Enhancement Platform
AIML Innovations Appoints Political Strategist and Public Affairs Leader, Michael Diamond, to Board of Directors
AIML Innovations Appoints Jared Adelstein to Board of Directors
AIML Announces Closing of Oversubscribed Private Placement
AIML Updates Terms of Proposed Private Placement Announced
AIML Announces Proposed Private Placement
AIML Continues to Streamline for the Future and Moves Beyond Tech2Heal
AIML Aligns Leadership for Growth and Shareholder Value Creation
Annual General and Special Meeting Results
AI/ML Innovations Inc. Key Updates to Upcoming Annual and Special Meeting
Andrea L. Ruth Joins AI/ML Innovations Inc. as Head of Quality, Clinical and Regulatory Affairs
AI/ML Innovations Inc. Appoints Dr. Alan Rabinowitz as Chief Medical Officer and Director of Medical Partnerships